
Vitalhub Corp. (TSE:VHI – Free Report) – Investment analysts at Cormark issued their Q3 2025 earnings per share estimates for shares of Vitalhub in a research report issued on Monday, October 27th. Cormark analyst G. Fairweather expects that the company will post earnings per share of $0.01 for the quarter. The consensus estimate for Vitalhub’s current full-year earnings is $0.23 per share. Cormark also issued estimates for Vitalhub’s FY2027 earnings at $0.38 EPS.
VHI has been the subject of several other research reports. Stifel Canada raised shares of Vitalhub to a “strong-buy” rating in a report on Tuesday, October 14th. Royal Bank Of Canada set a C$15.00 price objective on shares of Vitalhub and gave the company a “moderate buy” rating in a research report on Thursday, September 18th. Stifel Nicolaus set a C$15.00 target price on shares of Vitalhub and gave the company a “buy” rating in a research note on Wednesday, October 15th. TD Securities raised their price target on shares of Vitalhub from C$15.00 to C$16.00 and gave the company a “buy” rating in a research note on Monday, August 11th. Finally, National Bankshares set a C$16.00 price target on Vitalhub and gave the company an “outperform” rating in a report on Thursday, August 21st. Two investment analysts have rated the stock with a Strong Buy rating and seven have assigned a Buy rating to the company. According to MarketBeat, Vitalhub presently has a consensus rating of “Buy” and an average price target of C$14.86.
Vitalhub Price Performance
Shares of VHI opened at C$11.41 on Tuesday. Vitalhub has a 12 month low of C$8.50 and a 12 month high of C$14.64. The stock has a fifty day moving average price of C$11.47 and a 200 day moving average price of C$11.42. The company has a market cap of C$716.89 million, a P/E ratio of 142.63, a PEG ratio of 1.18 and a beta of 0.62.
Insider Transactions at Vitalhub
In other news, Director Danny Matlow sold 150,000 shares of the company’s stock in a transaction that occurred on Thursday, August 28th. The shares were sold at an average price of C$12.75, for a total value of C$1,912,500.00. Following the completion of the sale, the director directly owned 520,001 shares of the company’s stock, valued at approximately C$6,630,012.75. This represents a 22.39% decrease in their position. Also, Director Steve Garrington sold 20,000 shares of the firm’s stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of C$12.90, for a total transaction of C$258,000.00. Following the transaction, the director owned 60,000 shares in the company, valued at C$774,000. This represents a 25.00% decrease in their position. Corporate insiders own 18.57% of the company’s stock.
Vitalhub Company Profile
Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.
Featured Stories
- Five stocks we like better than Vitalhub
- Do ETFs Pay Dividends? What You Need to Know
- Growth Picks: 3 Low-Cost Stocks That Could Double in Value
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Are These 3 Beaten-Down Stocks Ready to Rebound?
- Short Selling – The Pros and Cons
- Does the Trump-Induced Quantum Stock Rally Have Legs?
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.
